Skip to main content
Oman Journal of Ophthalmology logoLink to Oman Journal of Ophthalmology
. 2021 Feb 27;14(1):60–61. doi: 10.4103/ojo.OJO_292_2019

Misdirected ozurdex implant

Amber Amar Bhayana 1,, Suneel Kumar 1, Shorya Vardhan Azad 1
PMCID: PMC8095309  PMID: 34084039

Abstract

Ozurdex is one of the most commonly inserted intravitreal steroid implants in cases of posterior uveitis and recalcitrant macular edema in cases of diabetic retinopathy and vascular occlusions. Here we report accidental malpositioning of this implant in patellar fossa.

Keywords: Implant, misdirected, Ozurdex


A 6-year-old female, known case of juvenile idiopathic arthritis, was injected intravitreally with Ozurdex (Allergan, Irvine, CA, USA) for chronic panuveitis in the left eye which got accidentally placed anteriorly and got trapped in the anterior hyaloid face indenting the posterior capsule of the crystalline lens [Figure 1]. The eye was treated with lens sparing pars plana vitrectomy with oil insertion for developing retinal detachment and Ozurdex was explanted. Misdirected implants are rare accidental complications during intravitreal injections.[1,2,3,4,5] Decision must be taken immediately whether to intervene to prevent vision loss due to complications.

Figure 1.

Figure 1

Slit lamp photograph of the left eye showing anteriorly placed dexamethasone implant with inferotemporal part trapped between posterior capsule and anterior hyaloid

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  • 1.Biswas P, Nandi K, Batra S, Ginodia A, Biswas P. Pars plana vitrectomy and re-directing a dexamethasone implant into vitreous cavity following misdirected entry into the crystalline lens. Indian J Ophthalmol. 2018;66:1033–6. doi: 10.4103/ijo.IJO_1179_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Chhabra R, Kopsidas K, Mahmood S. Accidental insertion of dexamethasone implant into the crystalline lens-12 months follow-up. Eye (Lond) 2014;28:624–5. doi: 10.1038/eye.2014.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Abdolrahimzadeh S, Plateroti P, Scarinci F, Plateroti AM. Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion. Acta Ophthalmol. 2016;94:e810–1. doi: 10.1111/aos.13062. [DOI] [PubMed] [Google Scholar]
  • 4.Baskan B, Cıcek A, Gulhan A, Gundogan M, Goktas S. Ozurdex completely located inside a crystallized lens-Results of 14 months. Am J Ophthalmol Case Rep. 2016;4:38–40. doi: 10.1016/j.ajoc.2016.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Chalioulias K, Muqit MM. Vitreoretinal surgery for inadvertent intralenticular Ozurdex implant. Eye. 2014;28:1523–4. doi: 10.1038/eye.2014.192. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Oman Journal of Ophthalmology are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES